Literature DB >> 28541132

How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?

Ramzi A Ajjan1.   

Abstract

Controlling glycemia in diabetes remains key to prevent complications in this condition. However, glucose levels can undergo large fluctuations secondary to daily activities, consequently creating management difficulties. The current review summarizes the basics of glucose management in diabetes by addressing the main glycemic parameters. The advantages and limitation of HbA1c, the gold standard measure of glucose control, are discussed together with the clinical importance of hypoglycemia and glycemic variability. The review subsequently moves focus to glucose monitoring techniques in diabetes, assessing advantages and limitations. Monitoring glucose levels is crucial for effective and safe adjustment of hypoglycemic therapy, particularly in insulin users. Self-monitoring of blood glucose (SMBG), based on capillary glucose testing, remains one of the most widely used methods to monitor glucose levels, given the relative accuracy, familiarity, and manageable costs. However, patient inconvenience and the sporadic nature of SMBG limit clinical effectiveness of this approach. In contrast, continuous glucose monitoring (CGM) provides a more comprehensive picture of glucose levels, but these systems are expensive and require constant calibration which, together with concerns over accuracy of earlier devices, restrict CGM use to special groups of patients. The newer flash continuous glucose monitoring (FCGM) system, which is more affordable than conventional CGM devices and does not require calibration, offers an alternative glucose monitoring strategy that comprehensively analyzes glucose profile while sparing patients the inconvenience of capillary glucose testing for therapy adjustment or CGM calibration. The fast development of new CGM devices will gradually displace SMBG as the main glucose testing method. Avoiding the inconvenience of SMBG and optimizing glycemia through alternative glucose testing strategies will help to reduce the risk of complications and improve quality of life in patients with diabetes.

Entities:  

Keywords:  Continuous glucose monitoring (CGM); Flash continuous glucose monitoring (FCGM); Glycemic variability; Hypoglycemia; Self-monitoring of blood glucose (SMBG); Type 1 diabetes (T1DM); Type 2 diabetes (T2DM)

Mesh:

Substances:

Year:  2017        PMID: 28541132      PMCID: PMC5444484          DOI: 10.1089/dia.2017.0021

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  73 in total

1.  Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.

Authors:  Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Shinsuke Yamada; Yasuo Imanishi; Tsutomu Tabata; Mikio Okamura; Shigeki Okada; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

2.  Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.

Authors:  Masaru Kuroda; Toshiro Shinke; Kazuhiko Sakaguchi; Hiromasa Otake; Tomofumi Takaya; Yushi Hirota; Daisuke Sugiyama; Masayuki Nakagawa; Hirotoshi Hariki; Takumi Inoue; Tsuyoshi Osue; Yu Taniguchi; Masamichi Iwasaki; Ryo Nishio; Hiroto Kinutani; Akihide Konishi; Noritoshi Hiranuma; Hachidai Takahashi; Daisuke Terashita; Ken-Ichi Hirata
Journal:  JACC Cardiovasc Interv       Date:  2015-05       Impact factor: 11.195

3.  A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes.

Authors:  Viktorija Matuleviciene; Jeffrey I Joseph; Mervi Andelin; Irl B Hirsch; Stig Attvall; Aldina Pivodic; Sofia Dahlqvist; David Klonoff; Börje Haraldsson; Marcus Lind
Journal:  Diabetes Technol Ther       Date:  2014-09-18       Impact factor: 6.118

Review 4.  Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis.

Authors:  Atsushi Goto; Onyebuchi A Arah; Maki Goto; Yasuo Terauchi; Mitsuhiko Noda
Journal:  BMJ       Date:  2013-07-29

5.  Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.

Authors:  Roy W Beck; Tonya Riddlesworth; Katrina Ruedy; Andrew Ahmann; Richard Bergenstal; Stacie Haller; Craig Kollman; Davida Kruger; Janet B McGill; William Polonsky; Elena Toschi; Howard Wolpert; David Price
Journal:  JAMA       Date:  2017-01-24       Impact factor: 56.272

6.  Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study.

Authors:  Kamlesh Khunti; Melanie Davies; Azeem Majeed; Brian Larsen Thorsted; Michael Lyng Wolden; Sanjoy K Paul
Journal:  Diabetes Care       Date:  2014-12-09       Impact factor: 19.112

7.  Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes.

Authors:  Boris Kovatchev; Claudio Cobelli
Journal:  Diabetes Care       Date:  2016-04       Impact factor: 19.112

8.  REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes.

Authors:  Grazia Aleppo; Katrina J Ruedy; Tonya D Riddlesworth; Davida F Kruger; Anne L Peters; Irl Hirsch; Richard M Bergenstal; Elena Toschi; Andrew J Ahmann; Viral N Shah; Michael R Rickels; Bruce W Bode; Athena Philis-Tsimikas; Rodica Pop-Busui; Henry Rodriguez; Emily Eyth; Anuj Bhargava; Craig Kollman; Roy W Beck
Journal:  Diabetes Care       Date:  2017-02-16       Impact factor: 19.112

9.  Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants.

Authors:  Kellee M Miller; Roy W Beck; Richard M Bergenstal; Robin S Goland; Michael J Haller; Janet B McGill; Henry Rodriguez; Jill H Simmons; Irl B Hirsch
Journal:  Diabetes Care       Date:  2013-02-01       Impact factor: 19.112

Review 10.  Glycemic Variability: How Do We Measure It and Why Is It Important?

Authors:  Sunghwan Suh; Jae Hyeon Kim
Journal:  Diabetes Metab J       Date:  2015-08       Impact factor: 5.376

View more
  18 in total

1.  Flash Glucose Monitoring: The Future Is Here.

Authors:  Satish K Garg; Halis Kaan Akturk
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

2.  Largest Amplitude of Glycemic Excursion Calculating from Self-Monitoring Blood Glucose Predicted the Episodes of Nocturnal Asymptomatic Hypoglycemia Detecting by Continuous Glucose Monitoring in Outpatients with Type 2 Diabetes.

Authors:  Shoubi Wang; Zhenhua Tan; Ting Wu; Qingbao Shen; Peiying Huang; Liying Wang; Wei Liu; Haiqu Song; Mingzhu Lin; Xiulin Shi; Xuejun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

Review 3.  A systematic review on clinical implication of continuous glucose monitoring in diabetes management.

Authors:  Anam Azhar; Syed W Gillani; Ghasna Mohiuddin; Rukhsar A Majeed
Journal:  J Pharm Bioallied Sci       Date:  2020-04-10

Review 4.  Review of Modern Insulin Pumps and the Perioperative Management of the Type 1 Diabetic Patient for Ambulatory Dental Surgery.

Authors:  Philip M Yen; Andrew S Young
Journal:  Anesth Prog       Date:  2021-10-01

5.  Flash glucose monitoring improves glycemia in higher risk patients: a longitudinal, observational study under real-life settings.

Authors:  Sujit Jangam; Timothy Dunn; Yongjin Xu; Gary Hayter; Ramzi A Ajjan
Journal:  BMJ Open Diabetes Res Care       Date:  2019-03-25

6.  Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System.

Authors:  Dorothee Deiss; Agnieszka Szadkowska; Debbie Gordon; Akhila Mallipedhi; Ingrid Schütz-Fuhrmann; Eva Aguilera; Corina Ringsell; Christophe De Block; Concetta Irace
Journal:  Diabetes Technol Ther       Date:  2019-04-25       Impact factor: 6.118

7.  Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open-label, 2:1 randomized, treat-to-target trial.

Authors:  Wenying Yang; Jianhua Ma; Tianpei Hong; Ming Liu; Heng Miao; Yongde Peng; Changjiang Wang; Xiangjin Xu; Tao Yang; Anne M Nielsen; Lili Pan; Weihong Liu; Weigang Zhao
Journal:  Diabetes Obes Metab       Date:  2019-04-04       Impact factor: 6.577

8.  Demonstrating the Clinical Impact of Continuous Glucose Monitoring Within an Integrated Healthcare Delivery System.

Authors:  Brad Isaacson; Stephanie Kaufusi; Jeff Sorensen; Elizabeth Joy; Christopher Jones; Valerie Ingram; Nickolas Mark; Mike Phillips; Mark Briesacher
Journal:  J Diabetes Sci Technol       Date:  2020-09-16

9.  Does Metformin Assist New Anti-Diabetic Drugs to Succeed?

Authors:  Hisayuki Kastuyama; Hidekatsu Yanai
Journal:  J Clin Med Res       Date:  2019-01-05

10.  The Accuracy and Precision of the Continuously Stored Data from Flash Glucose Monitoring System in Type 2 Diabetes Patients during Standard Meal Tolerance Test.

Authors:  Rengna Yan; Huiqin Li; Xiaocen Kong; Xiaofang Zhai; Maoyuan Chen; Yixuan Sun; Lei Ye; Xiaofei Su; Jianhua Ma
Journal:  Int J Endocrinol       Date:  2020-01-04       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.